Evidence map›Paper›PMID 41746131›Full record

ArticleTranslational vision science & technology2026

Interpretable Deep Learning for OCT-Based Diagnosis of Vitreoretinal Lymphoma Versus Uveitis.

Azaz Khan, Ogul E Uner, Pengxiao Zang, Christopher R Rosenberg, Eric B Suhler, Phoebe Lin, Christina J Flaxel, Yali Jia

Abstract read
In one paragraph

Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Azaz KhanCasey Eye Institute, Oregon Health & Science University, Portland, OR, USA.
Ogul E UnerCasey Eye Institute, Oregon Health & Science University, Portland, OR, USA.
Pengxiao ZangCasey Eye Institute, Oregon Health & Science University, Portland, OR, USA.
Christopher R RosenbergCasey Eye Institute, Oregon Health & Science University, Portland, OR, USA.
Eric B SuhlerCasey Eye Institute, Oregon Health & Science University, Portland, OR, USA.
Phoebe LinCasey Eye Institute, Oregon Health & Science University, Portland, OR, USA.
Christina J FlaxelCasey Eye Institute, Oregon Health & Science University, Portland, OR, USA.
Yali JiaCasey Eye Institute, Oregon Health & Science University, Portland, OR, USA.

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell · 1995 to 2026
$19.4M
OCT Angiography for Neovascular Age-related Macular DegenerationR01EY024544 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Steven T Bailey, Yali Jia · 2014 to 2026
$6.2M
OCTA Precursors of Vision-Threatening Complications of Diabetic RetinopathyR01EY035410 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Thomas Hwang, Yali Jia · 2023 to 2026
$2.5M
Translational Vision Science Research at Oregon Health & Science UniversityT32EY023211 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Yali Jia, Kate E Keller · 2013 to 2026
$2.4M
Advancing visible-light OCT in oxygen-induced retinopathyR01EY036429 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell, Yali Jia · 2024 to 2026
$2.0M
Wide-field and projection-resolved optical coherence tomography angiography in diabetic retinopathyR01EY027833 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI HWANG, THOMAS, JIA, YALI · 2017 to 2020
$1.8M
Visible-light OCT angiography, velocimetry, and oximetry for characterizing retinal vascular alterations in glaucomaR01EY031394 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI JIA, YALI, MORRISON, JOHN C · 2020 to 2022
$1.6M
Functional Optical Coherence Tomography-derived Biomarkers for Diabetic RetinopathyDP3DK104397 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI JIA, YALI, WILSON, DAVID J · 2014 to 2014
$1.0M
A diagnostic platform for diabetic retinopathy based on OCT angiography and artificial intelligenceR43EY036781 · NEI · IFOCUS IMAGING LLC · PI HORMEL, TRISTAN, JIA, YALI · 2024 to 2024
$306k
NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY024544NEI NIH HHS R01 EY027833NEI NIH HHS R01 EY031394NEI NIH HHS R01 EY035410NEI NIH HHS R01 EY036429NEI NIH HHS R43 EY036781NEI NIH HHS T32 EY023211NIDDK NIH HHS DP3 DK104397
6 · The paper itself

Abstract

Purpose: To develop and validate an interpretable deep learning model that classifies optical coherence tomography (OCT) scans as vitreoretinal lymphoma (VRL) or non-infectious uveitis (NIU)-intermediate, posterior, or panuveitis-and visualizes differentiating pathological OCT features. Methods: This cross-sectional study included 45 patients with VRL and 52 with NIU who underwent SPECTRALIS OCT imaging. OCT B-scans were analyzed with a custom-designed deep convolutional neural network classification model combined with gradient-weighted class activation mapping (Grad-CAM). Interpretability was assessed using Grad-CAM heat maps that visualize disease-specific OCT features. We evaluated diagnostic performance at the eye level using the area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), accuracy, F1 score, precision, sensitivity, specificity, and kappa. Results: The model differentiated VRL from NIU at the eye level, with mean ± SD scores of 76.0 ± 8.0 for AUROC, 79.4 ± 10.4 for AUPRC, 75.4 ± 13.3 for accuracy, 74.9 ± 13.7 for F1 score, 73.9 ± 19.3 for precision, 77.7 ± 13.6 for sensitivity, 73.4 ± 20.7 for specificity, and 51.0 ± 26.6 for kappa. Grad-CAM features of VRL included preretinal deposits and changes in the retinal pigment epithelium. In contrast, NIU features included denser vitreous cells and opacities, epiretinal membrane, intraretinal cells, and choroidal and scleral abnormalities consistent with NIU pathophysiology. Conclusions: A deep learning model with interpretability can reliably differentiate VRL from NIU, highlighting disease-relevant OCT features. Translational Relevance: The proposed deep learning method may serve as a non-invasive triage tool by identifying patients who need confirmatory pars plana vitrectomy.

Identifiers

PMID41746131
PMCPMC12949475

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.